TCON
$2.60
Tracon Pharma
$.01
.39%
TCON
Earnings Whisper ®
N/A
4th Quarter December 2021
Consensus:  ($0.35)
Revenue:  $0.00 Mil
Wednesday
Feb 2
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when TCON reports earnings?
Beat
Meet
Miss

Where is TCON's stock price going from here?
Up
Flat
Down
Stock chart of TCON
Analysts
Summary of analysts' recommendations for TCON
Score
Grade
Pivots
Resistance
$3.17
$2.99
$2.79

$2.61

Support
$2.41
$2.23
$2.03
Tweet
Growth
Description
TRACON Pharmaceuticals, Inc. is a biopharmaceutical company. The company's product candidate includes TRC105, TRC205 and TRC102 which are in different clinical stage for cancer, age-related macular degeneration and fibrotic diseases. TRACON Pharmaceuticals, Inc. is headquartered in San Diego, California.
Peers
USANA Health Sciences